H36.82
Proliferative sickle-cell retinopathy
Clinical Classification Guidelines
Medical Intelligence & Overview
Proliferative sickle-cell retinopathy is an eye condition that affects individuals with sickle cell disease, a hereditary blood disorder. This condition involves abnormal blood vessel growth in the retina, the light-sensitive tissue at the back of the eye. Over time, these abnormal vessels can lead to severe complications, including vision loss. Recognizing the signs early and understanding the potential causes and treatment options are essential for managing this eye disease effectively.
Causes & Symptoms
Clinical Causes: Sickle cell disease, a genetic blood disorder characterized by abnormal hemoglobin that causes red blood cells to adopt a sickle shape. Chronic blood vessel damage in the retina due to sickled cells obstructing blood flow. Repeated episodes of vaso-occlusion, leading to ischemia and the subsequent formation of abnormal blood vessels. Genetic predisposition in individuals with sickle cell trait or sickle cell disease, which influences the severity of retinal changes.
Key Symptoms: Gradual loss of vision in one or both eyes. Blurred or distorted vision, making objects appear wavy or bent. The appearance of floaters, spots, or shadows in the visual field. Sudden, painless loss of vision if new abnormal vessels bleed.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an ophthalmologist, including dilation of the pupils to visualize the retina. Specific diagnostic procedures may include:
Treatment Protocols: Managing proliferative sickle-cell retinopathy focuses on preventing further vision loss and addressing existing retinal damage. Common treatment approaches include:
Clinical Advice & FAQs
Billing Guidance
Is H36.82 a billable ICD-10 code?
Yes, H36.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H36.82?
Clinical documentation must specify the nature of Proliferative sickle-cell retinopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference